Gen Biotechnology
Overview
Gen Biotechnology is a scientific journal, published since 2022 in English. The journal's country of origin is United States and its primary focus area is biotechnology.
Details
Details
Abbr.
GEN Biotechnol
Start
2022
End
Continuing
Frequency
Bimonthly
p-ISSN
2768-1572
e-ISSN
2768-1556
Country
United States
Language
English
Specialty
Biotechnology
Recent Articles
1.
Chen Z, Kelly K, Cheng H, Dong X, Hedger A, Li L, et al.
GEN Biotechnol
. 2025 Jan;
2(6):490-502.
PMID: 39850578
Prime editing has gained significant attention as a next-generation gene editing technology, owing to its unique advantages. However, realizing its potential requires effective delivery strategies. While adeno-associated virus (AAV) has...
2.
Liang G, Yin H, Ding F
GEN Biotechnol
. 2024 Nov;
2(5):384-398.
PMID: 39544230
Transcriptomics is one of the largest areas of research in biological sciences. Aside from RNA expression levels, the significance of RNA spatial context has also been unveiled in the recent...
3.
Kartiganer Z, Rojas G, Riccio M, Tyree A, Noronha K, Wetzel M, et al.
GEN Biotechnol
. 2024 Oct;
2(6):503-514.
PMID: 39380764
Gene expression is subject to epigenetic regulation and is dependent upon cellular context. Spatial omics tools can provide insight into cellular context; however, development has centered on spatial transcriptomics and...
4.
Kwon S, Parthiban S, Tippani M, Divecha H, Eagles N, Lobana J, et al.
GEN Biotechnol
. 2024 Sep;
2(5):399-417.
PMID: 39329069
Neuropathological lesions in the brains of individuals affected with neurodegenerative disorders are hypothesized to trigger molecular and cellular processes that disturb homeostasis of local microenvironments. Here, we applied the 10x...
5.
Liu J, Rayes D, Akbari O
GEN Biotechnol
. 2024 Feb;
3(1):35-44.
PMID: 38415050
Recent advances in insect genetic engineering offer alternative genetic biocontrol solutions to control populations of pests and disease vectors. While success has been achieved, sex-sorting remains problematic for scaling many...
6.
Luk K, Liu P, Zeng J, Wang Y, Maitland S, Idrizi F, et al.
GEN Biotechnol
. 2024 Feb;
1(3):271-284.
PMID: 38405215
Type V CRISPR-Cas12a systems are an attractive Cas9-alternative nuclease platform for specific genome editing applications. However, previous studies demonstrate that there is a gap in overall activity between Cas12a and...
7.
8.
Michaels Y, Durland L, Zandstra P
GEN Biotechnol
. 2023 Nov;
2(2):106-119.
PMID: 37928777
Engineered T cells are at the leading edge of clinical cell therapy. T cell therapies have had a remarkable impact on patient care for a subset of hematological malignancies. This...
9.
Shum D, Bhinder B, Mahida J, Radu C, Calder P, Djaballah H
GEN Biotechnol
. 2023 Nov;
2(2):133-148.
PMID: 37928776
Dengue is the most common mosquito-borne viral disease that in recent years has become a major international public health concern. Dengue is a tropical neglected disease with increasing global incidences,...
10.
Hong L, Williams N, Jaffe M, Shields C, Haynes K
GEN Biotechnol
. 2023 Nov;
2(4):301-316.
PMID: 37928406
Scientists have used pharmacological inhibitors of polycomb proteins to restore the expression of tumor suppressor genes and stop cancer proliferation and invasion. A major limitation of this approach is that...